A retrospective study by Monaco Let al. (20) included 92 lung cancer patients treated with PD-1/PD-L1 monotherapy and found that the baseline PET metabolic parameter MTVwb was an independent predictor of ICIs treatment response. The gene discussed is PDCD1; the disease is lung cancer.